![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 39/395 | |
C07K 16/00 | |||
C07H 21/04 |
(11) | Number of the document | 3212230 |
(13) | Kind of document | T |
(96) | European patent application number | 15854895.8 |
Date of filing the European patent application | 2015-10-29 | |
(97) | Date of publication of the European application | 2017-09-06 |
(45) | Date of publication and mention of the grant of the patent | 2021-01-20 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2015/058108 |
Date | 2015-10-29 |
(87) | Number | WO 2016/069919 |
Date | 2016-05-06 |
(30) | Number | Date | Country code |
201462072031 P | 2014-10-29 | US | |
201562134955 P | 2015-03-18 | US |
(72) |
GARDAI, Shyra, US
LAW, Che-Leung, US
PENG, Stanford, US
YANG, Jing, US
NEFF-LAFORD, Haley, US
|
(73) |
Seagen Inc.,
21823 30th Drive, S.E., Bothell, WA 98021,
US
|
(54) | DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES |
DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES |